Cargando…

Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation

BACKGROUND: Epithelial to mesenchymal transition (EMT) has been connected with cancer progression in vivo and the generation of more aggressive cancer cell lines in vitro. EMT has been induced in prostate cancer cell lines, but has previously not been shown in primary prostate cells. The role of EMT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Xi-Song, Qu, Yi, Goldfinger, Naomi, Rostad, Kari, Hovland, Randi, Akslen, Lars A., Rotter, Varda, Øyan, Anne Margrete, Kalland, Karl-Henning
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2557125/ https://www.ncbi.nlm.nih.gov/pubmed/18852876 http://dx.doi.org/10.1371/journal.pone.0003368

Ejemplares similares

Amplification of the 20q Chromosomal Arm Occurs Early in Tumorigenic Transformation and May Initiate Cancer
por: Tabach, Yuval, et al.
Publicado: (2011)

Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells
por: Ke, Xi-Song, et al.
Publicado: (2010)

p63 Attenuates Epithelial to Mesenchymal Potential in an Experimental Prostate Cell Model
por: Olsen, Jan Roger, et al.
Publicado: (2013)

Genome-Wide Profiling of Histone H3 Lysine 4 and Lysine 27 Trimethylation Reveals an Epigenetic Signature in Prostate Carcinogenesis
por: Ke, Xi-Song, et al.
Publicado: (2009)

Hyperoxic Treatment Induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model
por: Moen, Ingrid, et al.
Publicado: (2009)

Dual Pro- and Anti-Inflammatory Features of Monocyte-Derived Dendritic Cells
por: Azeem, Waqas, et al.
Publicado: (2020)

Evaluation of β-Catenin Inhibition of Axitinib and Nitazoxanide in Human Monocyte-Derived Dendritic Cells
por: Azeem, Waqas, et al.
Publicado: (2021)

Proteasome-Mediated Regulation of GATA2 Expression and Androgen Receptor Transcription in Benign Prostate Epithelial Cells
por: Azeem, Waqas, et al.
Publicado: (2022)

An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells
por: Azeem, Waqas, et al.
Publicado: (2017)

Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia
por: Øyan, Anne Margrete, et al.
Publicado: (2009)

Switch in FOXA1 Status Associates with Endometrial Cancer Progression
por: Tangen, Ingvild Løberg, et al.
Publicado: (2014)

Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes
por: Olsen, Jan Roger, et al.
Publicado: (2016)

Mutant p53-dependent mitochondrial metabolic alterations in a mesenchymal stem cell-based model of progressive malignancy
por: Lonetto, Giuseppe, et al.
Publicado: (2018)

Expression of circadian clock genes and proteins in urothelial cancer is related to cancer-associated genes
por: Litlekalsoy, Jorunn, et al.
Publicado: (2016)

p53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner
por: Molchadsky, Alina, et al.
Publicado: (2008)

Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation
por: Moen, Ingrid, et al.
Publicado: (2012)

p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production
por: Goldstein, Ido, et al.
Publicado: (2013)

Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells
por: Sarig, Rachel, et al.
Publicado: (2010)

p53, a novel regulator of lipid metabolism pathways
por: Goldstein, Ido, et al.
Publicado: (2012)

Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner
por: Charni-Natan, Meital, et al.
Publicado: (2018)

Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
por: Tal, Perry, et al.
Publicado: (2019)

Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
por: Tal, Perry, et al.
Publicado: (2016)

Lipocalin 2 expression is associated with aggressive features of endometrial cancer
por: Mannelqvist, Monica, et al.
Publicado: (2012)

Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival
por: Mauland, Karen Klepsland, et al.
Publicado: (2016)

Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses
por: Bredholt, Geir, et al.
Publicado: (2015)

Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain
por: Hua, Yaping, et al.
Publicado: (2022)

Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System
por: Nordgård, Oddmund, et al.
Publicado: (2021)

Modulated expression of WFDC1 during carcinogenesis and cellular senescence
por: Madar, Shalom, et al.
Publicado: (2009)

Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients
por: Mauland, Karen Klepsland, et al.
Publicado: (2017)

Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino‐terminal domain
por: Hua, Yaping, et al.
Publicado: (2018)

TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model
por: Leshem, Orit, et al.
Publicado: (2011)

Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma
por: Engelsen, I B, et al.
Publicado: (2008)

High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer
por: Mauland, K K, et al.
Publicado: (2011)

Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer
por: Stefansson, Ingunn M., et al.
Publicado: (2015)

A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer
por: Thomsen, Liv Cecilie Vestrheim, et al.
Publicado: (2023)

Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts-Secreted Interferon Beta
por: Madar, Shalom, et al.
Publicado: (2013)

Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation
por: Aylon, Yael, et al.
Publicado: (2009)

The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation
por: Tabach, Yuval, et al.
Publicado: (2005)

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
por: Krakstad, C, et al.
Publicado: (2012)

Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers
por: Solomon, Hilla, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oduvjvic7np99mtafetd6k7lvr